About Lung Cancer

Diabetes drug may keep lung cancer at bay

2010-09-01T22:30:38Z

CHICAGO (Reuters) - The common diabetes drug metformin may hold promise as a way to keep smokers from developing lung cancer, U.S. researchers said on Wednesday. They said metformin prevented lung tumor growth in mice exposed to a cancer-causing agent found in tobacco smoke, and because it is already widely used in people, it may be worth ...

Roche's Avastin gives best lung cancer survival rate

2010-08-06T00:15:21Z

ZURICH (Reuters) - Roche's top-selling Avastin helps patients with the most common form of lung cancer live longer than any other treatment, the Swiss drugmaker said on Friday, giving the drug a boost after a slew of setbacks. A late-stage trial showed first-line Avastin-based therapy in advanced non-small cell adenocarcinoma of the lung resulted in a median overall survival of...

Onyx, Bayer say Nexavar fails in lung cancer study

2010-08-25T14:47:39Z

Bayer and Onyx Pharmaceuticals say Nexavar does not meet study goal as a lung cancer treatment

Bayer HealthCare and Onyx Pharmaceuticals Inc. said Monday their cancer treatment Nexavar failed to boost survival in a clinical study involving patients with a certain type of advanced lung cancer...

Abraxis says Abraxane works better than Taxol

2010-06-07T06:45:09Z

Abraxis BioScience says data shows Abraxane works better than Taxol in lung cancer study

Abraxis BioScience said data from a late-stage study in lung cancer patients showed its drug Abraxane worked better than Taxol when given in combination with a chemotherapy drug. Abraxane is a chemotherapy agent...

New lung cancer treatment shrinks some tumors: study

2010-06-05T12:15:50Z

A new experimental drug helps shrink tumors in lung cancer patients with a specific form of genetic alteration, according to results from a clinical trial unveiled Saturday. The Pfizer Inc. drug crizotinib shrank tumors in patients with advanced non-small cell lung cancer (NSCLC) with a specific gene alteration of an enzyme implicated in cancer cell growth, known as anaplastic lymphoma kinase, or ALK. According to Pfizer, around 10,00...

Lung cancer drug shows big promise in early tests

2010-06-05T07:45:13Z

Pfizer drug shows big promise in early testing for lung cancer patients with a certain gene

Doctors are reporting unusually high success rates from early tests of an experimental lung cancer drug. The drug, called crizotinib, (crih-ZAH-tin-ib), is made by Pfizer Inc. It targets a gene that is found in about 4 percent of lung cancers, which amounts to 10,000 people a year in the Reuters) - An experimental drug being developed by Pfizer Inc that targets a specific gene mutation demonstrated impressive anti-tumor activity in patients with advanced non-small cell lung cancer (NSCLC), according to data from a small study presented on Saturday. More than half of the patients treated with the drug, crizotinib, experienced significant tumor ...

Inhaled drug may prevent lung cancer: study

2010-05-18T12:15:18Z

WASHINGTON (Reuters) - A drug approved to treat a range of conditions may also work to prevent lung cancer in people who have given up smoking, U.S. researchers reported on Tuesday. The drug, called iloprost, is approved in inhaled forms to treat pulmonary hypertension, when blood pools near the lungs, a connective tissue disease called scleroderma and a nerve condi...

Britons lag behind Swedes in lung cancer survival

2010-04-29T07:45:19Z

NEW YORK (Reuters Health) - Almost twice as many Swedes as Britons survive the first five years after a lung cancer diagnosis, a new report reveals. By examining nationwide cancer registries and death certificates in three countries, doctors found that survival rates for men dropped from 11.3 percent in Sweden, to 9.3 percent in Norway,...

Testing lung tumors tailors chemotherapy

2010-04-18T13:45:06Z

WASHINGTON (Reuters) - Researchers said they helped advanced lung cancer patients fare better by matching their tumors to targeted drugs, in what they said is the first significant trial to show it is possible to choose the best drug for an individual patient. They tested four so-called targeted therapies in patients with specific biomarkers -- mutations that the drugs were designed to counteract. After eight weeks, 46 per...

Gene found that may predict lung cancer in smokers

2010-04-07T13:31:00Z

WASHINGTON (Reuters) - Researchers have identified a group of genes that are especially active in lung cancer patients -- even in healthy tissue -- and said they may be used to predict which smokers will eventually develop lung cancer. And, they said, a natural supplement derived from food that is being tested to prevent lung cancer appears to halt the precancerous changes. "Even in normal cells or premalignant cells prior...

US researchers identify smokers with highest cancer risk

2010-04-07T13:16:07Z

Scientists using a genetic-based approach have found a method for identifying cigarette smokers with the highest risk of developing lung cancer, according to a study released Wednesday. Researchers from Boston University School of Medicine and the University of Utah said they used "a genomic approach to prevent lung cancer in ...

Lung cancer gene tests not ready: U.S. report

2010-03-16T14:32:38Z

WASHINGTON (Reuters) - Genetic tests designed to predict how well lung cancer patients will fare after treatment do very little to guide doctors, government researchers said on Tuesday. Their review of studies aiming to show a gene signature for lung tumors found serious problems in the design and analysis of the studies. Researchers need some clear guidelines to follow in what is becoming a booming industry of using genes...

New radiation therapy shows promise in lung cancer

2010-06-26T05:33:22Z

CHICAGO (Reuters) - Aiming powerful beams of radiation precisely at tumors helped control their growth and helped people with early stage but inoperable lung cancer live longer, U.S. researchers said on Tuesday. They said intensive radiation therapy -- done in one to five treatments instead of the conventional 20 to 30 -...

Pfizer ends study on potential lung cancer drug

2010-03-11T15:30:17Z

Pfizer ends study on potential lung cancer drug, committee says it won't meet treatment goal

Pfizer Inc. said Thursday it discontinued a late-stage study of the drug candidate figitumumab in patients with late-stage lung cancer, citing a lack of effectiveness. The company said an independent monitoring committee recommended stopping the study. It concluded that figitumumab in conjunction with

Occupation a key factor in men's lung cancer risk

2010-04-16T07:06:19Z

NEW YORK (Reuters Health) - Men who work in certain occupations continue to be at increased risk of lung cancer, new research from Italy shows. In fact, about 5 percent of lung cancers in men are job-related, Dario Consonni of the IRCCS Ospedale Maggiore Policlinico in Milan and as...

Researchers find sex-specific lung cancer genes

2010-06-11T21:24:50Z

WASHINGTON (Reuters) - Lung cancer is often dramatically different in women than it is in men, U.S. researchers reported on Tuesday in another study that suggests ways to tailor treatment for cancer patients. They also found that some elderly patients have forms of lung cancer that make them likely to benefit from chemotherapy, even though the treatments can be hars...

Men who eat soy may have lower lung cancer risk

2010-04-16T07:11:32Z

NEW YORK (Reuters Health) - Men who don't smoke and eat a lot of soy may have a lower risk of lung cancer, according to a new study. Soy contains isoflavones, which act similarly to the hormone estrogen, and may have anti-cancer qualities in hormone-related cancers of the breast and prostate, the researchers note in the American Journal...

Steeleye Span's Tim Hart dies at age 61

2010-04-16T08:01:21Z

LOS ANGELES (Reuters) - Tim Hart, a founding member of British folk-rock group Steeleye Span, has died of lung cancer, the band's record company said on Wednesday. Hart died on December 24 at age 61 in the home he had made in Sp...

Pfizer ends late-stage lung-cancer study

2010-04-16T08:03:00Z

NEW YORK (Reuters) - Pfizer Inc said on Tuesday it has ended a late-stage lung cancer study of its experimental drug figitumumab after an analysis showed it was unlikely to meet the main goal of improving overall survival. The analysis by an independent safety monitors found that adding figitumumab to two older therapies -- paclitaxel and carboplatin -- would be unlikel...

Lung cancer: New drug shows promise in lab mice

2010-04-16T08:09:36Z

A new category of drug brakes the growth of treatment-resistant lung cancer among lab mice, according to a study published on Thursday in the science journal Nature. The new type could add powerfully to a small family of drugs called epidermal growth factor receptor (EPFR) inhibitors, say its finders. It tackles mutations in a specific form of lung tumour that often becomes hardened to frontline treatment, acco...

Scientists crack gene code of common cancers

2010-04-16T08:20:29Z

Two common forms of cancer have been genetically mapped for the first time, British scientists announced, in a major breakthrough in understanding the diseases. The maps have exposed the DNA mutations that lead to skin and lung cancers, in a discovery scientists said could transform the way these diseases are diagnosed and treated in coming years. All cancers are caused by damage to genes -- mutations in DNA -- that can be triggered by environmental factors such as tobacco smoke, harmful...

Junior miner jumps on gold production agreement

2010-04-16T09:48:24Z

Restarting gold production made more than a few shareholders happy Thursday, while an Asian deal boosted a healthcare stock.

'+company+ ' (TSX: '+exchange+'.'+symbol+', Stock Forum)'+percent+'

Stockhouse Canadian Small ...

Pfizer halts enrollment in lung cancer trial

2010-04-16T09:54:25Z

NEW YORK (Reuters) - Pfizer Inc has halted patient enrollment in a late-stage lung cancer trial of its experimental drug, figitumumab, for safety reasons, the drugmaker said on Friday. The halt was recommended by independent safety monitors overseeing the study. In their review, the monitors found more serious adverse events, including deaths, with patients receiving fi...

WHO: Nations should set tighter radon controls

2010-04-16T10:11:45Z

WHO urges nations to set tighter radon controls in homes to reduce lung cancer risks

The World Health Organization on Tuesday drastically reduced the amount of radon from natural sources that countries should allow to accumulate in buildings, given the fatal lung cancer it can cause. Radon is a naturally occurring gas found in mines, caves and water treatment plants. But radon contai...

WHO slashes radon limit in homes, cites lung cancer

2010-04-16T10:11:45Z

GENEVA (Reuters) - The World Health Organization (WHO) has drastically cut the maximum amount of radon, a naturally occurring gas, that should be permitted in homes because of strong evidence it causes lung cancer. In a WHO Handbook on Indoor Radon issued quietly on Monday, it called for public health authorities and the construction industry...

WHO slashes safety limits of radioactive radon

2010-04-16T10:11:46Z

The World Health Organization has slashed the safety limits of radon to a tenth of its current level, noting that the naturally occurring radioactive gas causes up to 14 percent of lung cancer cases. "In view of the latest scientific data, WHO proposes a reference level of 100 becquerels per metric cube to minimize health hazards due to indoor radon exposure," said the CHICAGO (Reuters) - An Abbott Laboratories Inc unit that makes genetic tests will work with Pfizer Inc to develop a test to screen non-small cell lung cancer (NSCLC) tumors to determine which patients are good candidates for a novel cancer therap...

Iranians gathering to mourn Shiite leader's death

2010-04-16T10:38:00Z

Crowds of Iranians were gathering in front of the Iraqi embassy in Tehran on Thursday to mourn the death of Iraqi Shiite leader Abdel Aziz Al-Hakim who died from lung cancer. Hakim, a former chain smoker, died on Wednesday in a Tehran hospital after battling lung cancer for 28 months. His body was expected to be taken from the Iraqi embassy to

Iraq Shiite leader Hakim 'dies in Tehran hospital'

2010-04-16T10:38:45Z

Iraqi Shiite leader Abdel Aziz al-Hakim has died in a Tehran hospital after a long battle with lung cancer, his son Mohsen Hakim told AFP. "He died a few minutes ago after battling cancer for 28 months," said Mohsen who was at his father's bedside with his brother Ammar.

Lung cancer pill Iressa beats chemo for certain patients, new study concludes

Four years after the government severely restricted its use, the lung cancer drug Iressa may be poised to make a comeback: A study concludes it can slow the deadly disease better than standard chemotherapy in certain patients. The research released Wednesday is the first to show Iressa can be more effective than chemotherapy as a first-line tre...

Blood test may diagnose lung cancer, company says

2010-04-16T10:58:14Z

WASHINGTON (Reuters) - A blood test that detects nine compounds in blood may offer a safe way to diagnose early cases of lung cancer, Celera Corporation reported on Tuesday. Such a test would allow quick treatment of lung cancer, which is usually not detected before it has spread, Celera, which became independent of US military base employee who died of lung cancer after being exposed to asbestos. The district court outside Tokyo ruled the government, which hires local workers to support US forces, had failed to take appropriat...

Hormone pills may make lung cancer more deadly

2010-04-16T12:02:51Z

Hormone pills for menopause may make lung cancer more deadly, women's health study suggests

There's more troubling news about hormone therapy for menopause symptoms: Lung cancer seems more likely to prove fatal in women who are taking estrogen-progestin pills, a study suggests. Hormone users who developed lung cancer were 60 percent more likely to die from the disease as women who weren't taking hormones, according to results reported Saturday. The new findings me...

Season may not alter cancer survival in short term

2010-04-16T12:14:04Z

NEW YORK (Reuters Health) - Some studies have found that patients with certain cancers seem to survive longer when they're diagnosed during summer and autumn months, but it now appears that this may be largely due to higher death rates in general during winter months, report UK researchers from ...

Lung Cancer Diagnosis

2010-06-26T04:20:04Z

Lung Cancer Diagnosis By Jitesh Arora The detection of the lung cancer is done by screening of the suspected individuals - suspected individuals mean people who are indulged in smoking or people more than the age of 45. There is no change in the survival rate as a result of practicing screening of the suspected individuals by many government and international health organizations but one thing is clear patients who had gone under the screening and were put the diagnosis of the lung cance...

Lung Cancer in Dogs - Canine Cancer

2010-04-16T17:46:08Z

Lung Cancer In Dogs - Canine Cancer By [Http://Ezinearticles.Com/?Expert=Janet_Markowitz]Janet Markowitz Dogs, Just Like Humans Have Many Organs In Their Body, Such As Liver, Kidneys And Spleen Just To Name A Few, Which All Function In A Specific Way With A Special Job They Must Preform To Keep The Body Alive. Lung Is The Most Important Respiratory Organ As It Transports Oxygen To Bloodstream. The Majority Of Lung Cancers Are Carcinomas In Nature. Lung Cancer In Dogs Spreads Quite Rapidly...

NCI Launches First-Ever Study to Determine if Biomarkers Can Help Guide Treatment for Lung Cancer

2010-04-16T17:57:45Z

Today a large, national clinical trial for non-small cell lung cancer was launched to validate whether a biomarker can predict clinical benefit in the treatment of this disease. Biomarkers, which are molecules found in the body that can signal an abnormal process or disease, would identify a target, known as epidermal growth factor receptor (EGFR). This receptor can be increased in some lung cancers due to the presence of extra copies of its coding gene. These extra copies can result in activ...

Immunohistochemical Expression of Estrogen and Progesterone Receptors in Primary Pulmonary Neuroendocrine Tumors

2010-04-16T13:49:17Z

Lung carcinoma is the leading cause of mortality among women and men,1 and breast carcinoma is the second most common cause of death among women.1 Primary and secondary tumors are common in the lung, and therefore determining the origin is critical for management. Although imaging studies may suggest a pulmonary primary when a single nodule is present, and 2 or more nodules may favor metastases,2 neither solitary metastases3 nor multiple pulmonary primaries are uncommon.4 Also with great...

Lymphatic Vessel Density Is Not Associated With Lymph Node Metastasis in Non-Small Cell Lung Carcinoma

2010-04-16T13:49:17Z

It is accepted that angiogenesis is essential for tumors to grow and metastasize.1 There are several antiangiogenic therapies in various stages of clinical development. Although the idea of a "lymphangiogenic switch" has not been proven as of yet,2 it is well known that in particular cancers, such as breast and colon cancer, lymphatic metastasis is the predominant method of tumor spread. It is also an important means of tumor spread in lung carcinomas, as well as an important adverse pro...

Meet the Press Set Visit Goes for $1,500 at Charity Auction

2010-04-16T14:14:52Z

"I'm going to put it on my mantle," said Christopher Andersen. It was the night of Tuesday, Nov. 18, and Mr. Andersen was standing on the top deck of a multi-plateau ballroom in the Time Warner Center. Below him, hundreds of guests were strolling about sipping cocktails and inhaling mini-hamburgers. Mr. Andersen was cradling in his hands a large br...

Meet the Press Set Visit Goes for $1500 at Charity Auction

2010-04-16T14:16:44Z

"I'm going to put it on my mantle," said Christopher Andersen. It was the night of Tuesday, November 18th, and Mr. Andersen was standing on the top deck of a multi-plateau ballroom in the Time Warner Center. Below him, hundreds of guests were strolling about sipping cocktails and inhaling mini-hamburgers. Mr. Andersen was cradling in his hands a la...

Unproven Remedies Celebrities

2010-03-30T22:02:25Z

FILE - This 1980 file photo shows Steve McQueen in "The Hunter." When conventional medicine failed to halt his mesothelioma, a cancer of the lung lining, McQueen traveled to Mexico, where he was treated with everything from coffee enemas to laetrile, the now debunked remedy involving apricot pits. (AP Photo/File)

CYPRUS UN TALKS

2010-04-11T17:06:46Z

this May 1, 2004 file photo shows former Cypriot President Tassos Papadopoulos who died from lung cancer on Friday, Dec. 12, 2008. Papadopoulos, 74, was admitted to Nicosia General Hospital with severe breathing problems and was diagnosed with lung cancer. Papadopoulos was president of the ethnically divided island from 2003 to 2008. He led Greek ...